REMS
Clostridioides difficile
.Spectrum:
Absorption: Poorly absorbed from the GI tract.
Distribution: Widely distributed to tissues. Some penetration (2030%) of CSF.
Half-Life: Neonates: 610 hr; Children 3 mo3 yr: 4 hr; Children >3 yr: 22.3 hr; Adults: 58 hr (↑ in renal impairment).
Contraindicated in:
Use Cautiously in:
CV: hypotension
Derm: ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS, DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS, LINEAR IGA BULLOUS DERMATOSIS, rash, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS
EENT: ototoxicity
GU: nephrotoxicity
Hemat: eosinophilia, leukopenia
Local: phlebitis
MS: back and neck pain
Misc: chills, fever, HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS), vancomycin flushing syndrome (with rapid infusion)
Drug-drug:
Serious Systemic Infections
Renal Impairment
Endocarditis Prophylaxis in Penicillin-Allergic Patients
Diarrhea Due to C. difficile
Staphylococcal Enterocolitis
Lab Test Considerations:
Toxicity and Overdose:
C. difficile
-associated diarrhea. Orally administered vancomycin is not effective for other types of infections.IV Administration:
NDC Code